Unassociated Document
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported) August 9, 2007


VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)


 
Delaware
1-7598
94-2359345
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)


3100 Hansen Way, Palo Alto, CA
94304-1030
(Address of Principal Executive Offices)
(Zip Code)


Registrant's telephone number, including area code (650) 493-4000


Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On August 9, 2007, Allen S. Lichter, M.D., announced his intention to resign from the Board of Directors of Varian Medical Systems, Inc. (the “Company”), effective October 1, 2007, in order to devote full attention to his duties as the Chief Executive Officer of the American Society of Clinical Oncology. Dr. Lichter has served as a director of the Company since 2003.
 
There has been no disagreement with Dr. Lichter as to the Company's policies, operations or practices.
 

 

 
 
 


SIGNATURES
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
   
  Varian Medical Systems, Inc.
 
 		  
 		  
 
Dated: August 10, 2007 By:   /s/ John W. Kuo
 
Name: John W. Kuo
  Title:   Corporate Vice President, General Counsel and Secretary